News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
What you need to know about Moderna’s new COVID vaccine, just approved by the FDA
Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID vaccine, but only for specific populations: all adults 65 and over and those between 12 and 64 with at least one underlying risk factor as defined by the Centers for Disease Control and Prevention.
The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food and Drug Administration has approved a COVID-19 vaccine from Moderna that ...
The US Department of Health and Human Services is terminating a contract with drugmaker Moderna to develop a vaccine to ...
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...
In May, prominent members of the Make America Great Again movement, including Nicole Shanahan, Kennedy's former presidential running mate, and media personality Laura Loomer, spoke out against Kennedy ...
3don MSN
Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback